Yahoo! Finance: Top Stories

Amgen Announces Significant Survival Benefit for Lung Cancer Drug IMDELLTRA in Phase 3 Trial

Jun 16, 2025 - 19:38
 0
Amgen Announces Significant Survival Benefit for Lung Cancer Drug IMDELLTRA in Phase 3 Trial
Read More

Tags:

Previous Article

Regeneron, Sanofi Announce Positive Dupixent Results for Atopic Dermatitis

Next Article

RBC Capital Lifts Gilead Sciences (GILD) PT to $95 On Insights From a 2022 Patie...

Related Posts

US Geological Survey identifies significant oil and gas potential in Wyoming

US Geological Survey identifies significant oil and gas...

May 23, 2025  0

These Stocks Moved the Most Today: Broadcom, Tesla, Dollar Tree, ON Semi, CrowdStrike, Guidewire, Asana, and More

These Stocks Moved the Most Today: Broadcom, Tesla, Dol...

Jun 6, 2025  0

Robson, Toublan on Economic Data, Yields, Foreign Buyers

Robson, Toublan on Economic Data, Yields, Foreign Buyers

Jun 1, 2025  0